EMSLR

gene
On this page

Also known as EMSBCCE4

Summary

EMSLR (E2F1 mRNA stabilizing lncRNA, HGNC:54408) is a long non-coding RNA gene on chromosome 7q22.1.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:54408
Approved symbolEMSLR
NameE2F1 mRNA stabilizing lncRNA
Location7q22.1
Locus typeRNA, long non-coding
StatusApproved
AliasesEMS, BCCE4
Ensembl geneENSG00000232445
Ensembl biotypelncRNA
OMIM618575
Entrez101927746
RNAcentralURS0000A76561 — lncRNA, 1098 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 lncRNA

ENST00000419422, ENST00000663483, ENST00000849561

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000419422 — 3 exons

ExonStartEnd
ENSE00001651575101310484101311343
ENSE00001680564101308296101308548
ENSE00003887252101309614101309694

Expression profiles

Bgee: expression breadth ubiquitous, 140 present calls, max score 85.98.

FANTOM5 (CAGE): breadth broad, TPM avg 4.2537 / max 149.3065, expressed in 765 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
801944.2537765

Top tissues by expression

227 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
buccal mucosa cellCL:000233685.98silver quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099179.13silver quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047377.31gold quality
body of pancreasUBERON:000115068.32gold quality
cortical plateUBERON:000534366.02gold quality
pancreasUBERON:000126465.13gold quality
esophagus mucosaUBERON:000246964.19gold quality
mucosa of transverse colonUBERON:000499163.98gold quality
ventricular zoneUBERON:000305363.03gold quality
hindlimb stylopod muscleUBERON:000425262.69gold quality
oocyteCL:000002362.46silver quality
right lobe of liverUBERON:000111461.80gold quality
lower esophagus mucosaUBERON:003583461.52gold quality
ganglionic eminenceUBERON:000402361.22gold quality
islet of LangerhansUBERON:000000660.39gold quality
muscle of legUBERON:000138359.31gold quality
body of stomachUBERON:000116158.89gold quality
gastrocnemiusUBERON:000138858.62gold quality
lower lobe of lungUBERON:000894958.24silver quality
prefrontal cortexUBERON:000045158.15gold quality
esophagusUBERON:000104358.15gold quality
liverUBERON:000210757.10gold quality
adult mammalian kidneyUBERON:000008256.99gold quality
stomachUBERON:000094556.70gold quality
leukocyteCL:000073855.90silver quality
cortex of kidneyUBERON:000122555.27gold quality
metanephros cortexUBERON:001053354.63gold quality
monocyteCL:000057654.15silver quality
olfactory segment of nasal mucosaUBERON:000538654.15gold quality
transverse colonUBERON:000115753.90gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.51

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 3)

  • Study reports the lncRNA E2F1 mRNA stabilizing factor (EMS) as a direct c-Myc transcriptional target. EMS functions as an oncogenic molecule by promoting G1/S cell cycle progression. EMS cooperates with the RNA binding protein RALY to stabilize E2F1 mRNA, and thereby increases E2F1 expression. Furthermore, EMS is able to connect c-Myc to cell cycle control and tumorigenesis via modulating E2F1 mRNA stability. (PMID:31262817)
  • Reciprocal modulation of long noncoding RNA EMS and p53 regulates tumorigenesis. (PMID:35022235)
  • E2F1-induced lncRNA, EMSLR regulates lncRNA LncPRESS1. (PMID:35169159)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.